Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

New US patent approval for Episurf Medical

Episurf Medical (NASDAQ: EPIS B) has received another Notice of Allowance from the United States Patent and Trademark Office (USPTO). The patent, entitled “Customization of individualized implant”, relates to a system for customizing an implant for treatment of damage in an anatomical joint of a patient. “This addresses the process for, in an efficient way, creating optimized, individualized implants for each patient’s joint damage, based on Episurf Medical’s medical imaging technology. We appreciate this first approval in this patent family”, comments Katarina Flodström, COO, Episurf

Amendment: Heliospectra (publ) Publish the Year-End Report for 2022

(GOTHENBURG, Sweden, March 1, 2023, at 09:40 CET) – Heliospectra AB (publ (Nasdaq First North Growth Market: HELIO), a world leader in intelligent lighting technology for greenhouse and controlled plant growth environments, presents its’ Year-End Report for 2022. The amendment regards order intake for the period October to December 2022.Full report is enclosed to this press release and is also uploaded at https://www.heliospectra.com/investor-relations/reports-documents-archive. SUMMARY OF REPORT Financial Performance for the period October to December · Order intake during the

Extensive range of Wärtsilä solutions chosen for two Chilean Navy vessels

Wärtsilä Corporation, Press release, 1 March 2023 at 10.30 AM EETThe technology group Wärtsilä will supply the main propulsion machinery, as well as a range of other equipment and systems for two new 110-metre long amphibious transport vessels being built for the Chilean Navy. The order was placed by Astilleros y Maestranzas de la Armada (Asmar), the state-owned shipyard constructing the vessels and it was included in Wärtsilä’s order book in February 2023. The Escotillón IV project, under which these ships are being built, will not only increase Chile’s defence capabilities, but will

Hydro has completed the acquisition of Hueck

Hydro completed the acquisition of Hueck on 28th February following approval from competition authorities in Germany and Austria. The acquisition strengthens Hydro Building Systems’ position in Europe and complement its footprint.Hueck is a family-owned business and provider of aluminium systems and extruded aluminium profiles, with headquarters in Lüdenscheid Germany. It has 500 employees, two extrusion presses and an integrated cast house operation. Hueck is divided into two businesses: Extrusion and Systems.   Germany is the largest segment of the European market for building

Hydro has completed the acquisition of Hueck

Hydro completed the acquisition of Hueck on 28th February following approval from competition authorities in Germany and Austria. The acquisition strengthens Hydro Building Systems’ position in Europe and complement its footprint.Hueck is a family-owned business and provider of aluminium systems and extruded aluminium profiles, with headquarters in Lüdenscheid Germany. It has 500 employees, two extrusion presses and an integrated cast house operation. Hueck is divided into two businesses: Extrusion and Systems.   Germany is the largest segment of the European market for building

BioStock: Chosa eyes publication of phase IIb-results

Danish biotech Chosa Oncology has had an eventful start of 2023. Following the RhoVac-transaction, the company is eagerly awaiting reply from an ASCO abstract application to publish phase IIb-results with its drug candidate LiPlaCis. CEO Peter Buhl comments on the Q4 report released earlier this week.Read the full article at biostock.se : https://www.biostock.se/en/2023/03/chosa-eyes-publication-of-phase-iib-results/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Collaborative Robots to Grow at a 14% CAGR in the Pharmaceutical Industry

The use of collaborative robots or "cobots" is on the rise in the pharmaceutical industry. Pharmaceutical application takes up around 0.05% of the total medical robot market size. Valued at USD 553 million, the pharmaceutical robotic market is forecasted to grow at 15.7% CAGR to reach USD 2 billion by 2030. In hospital settings, pharmacy robots are often included under the category of hospital logistic robots. According to a report by Next Move Strategy Consulting, pharmaceutical and laboratory robots together accounted for 60% of the total hospital logistic robot a report by Next Move

Inflexion announces acquisition of Nomentia

Inflexion is pleased to announce it has entered into an agreement to acquire a majority stake in Nomentia, a leading European treasury and cash management software provider, from current investors PSG Equity (“PSG”), a leading growth equity firm partnering with software and technology-enabled services companies, and Verdane, a European specialist growth investor named one of the region’s most active software investors. The investment is being made by Inflexion Buyout Fund VI.Helsinki-headquartered Nomentia is a modular, cloud first software provider delivering a comprehensive portfolio of

Metacon’s subsidiary Helbio receives an order from the University of Western Macedonia

Metacon through its subsidiary Helbio has received an order from the University of Western Macedonia (“UoW”) in Kozani in Greece for an automated system for studies in the field of catalytic hydrogen production from biogas and bio-methane. The order value amounts to approximately 63 000 EUR and delivery is planned for the fourth quarter, 2023. Using raw biogas for hydrogen production is an attractive solution for producing renewable hydrogen as it is a very large and underutilized non-fossil energy source that exists locally in all countries. New catalytic materials are under development

Notice to the Annual General Meeting of Tietoevry Corporation

Tietoevry Corporation          STOCK EXCHANGE RELEASE          1 March 2023   10:00 a.m. EET Notice is given to the shareholders of Tietoevry Corporation (“Tietoevry” or the "company") to the Annual General Meeting to be held on Thursday 23 March 2023 at 4:00 p.m. Finnish time at Tietoevry’s premises, address Keilalahdentie 2-4, 02150 Espoo, Finland. The reception of attendees who have preregistered for the meeting and the distribution of voting tickets will commence at 3:00 p.m. (Finnish time). Shareholders can also exercise their right to vote by voting in advance. Instructions for

Publication of Lundberg's Annual and Sustainability Report 2022

L E Lundbergföretagen AB's Annual and Sustainability Report for the fiscal year 2022 is now available on the company's website, www.lundbergforetagen.se. The distribution of the printed publication will start in week 10 to shareholders and other stakeholders who has signed up for distribution. The report can also be ordered on the website at "Investor Relations/The share/ Shareholder service" or at information@lundbergs.se. Stockholm, March 1, 2023 L E Lundbergföretagen AB (publ) For further questions contactLars Johansson, Chief Financial Officer, + 46 (0) 11 21 65 00. The

Invitation to webcast about UPM’s growth and innovation in specialty packaging materials on 7 March 2023

(UPM, Helsinki, 1 March 2023 at 10:00 EET) – UPM will arrange a webcast about its growth and product innovation in specialty packaging materials for investors, analysts and bankers on 7 March 2023 at 15:00–16:00 EET. Global megatrends are driving demand growth for sustainable and safe labelling and packaging solutions. UPM continues to expand in the specialty paper and self-adhesive label materials segments. The businesses innovate and expand the product portfolio to minimise dependency on fossil-based materials. UPM Specialty Papers has extensive expertise in technically demanding

Vestas and KK Wind Solutions strengthen partnership with transfer of converters and controls business

News release from Vestas Wind Systems A/SAarhus, 1 March 2023The sale of Vestas’ converters and controls business has been completed and marks the transfer of Vestas’ three converters and controls factories to KK Wind Solutions (KK). Around 600 of Vestas’ highly experienced and skilled colleagues will join KK. Following the acquisition, KK becomes a world leader within converter and controls for the wind industry Vestas continuously looks for partners that can support our strategic focus on our core business and help scale renewables efficiently in the long-term. As part of the

Shirley Ryan AbilityLab receives US Department of Defense grant for clinical study of Integrum’s e-OPRA Implant System

Mölndal, Sweden, March 1[st] , 2023 – Integrum (publ) (Nasdaq First North Growth Market: INTEG B) today announced that Shirley Ryan AbilityLab – a top-ranked physical medicine and rehabilitation hospital based in Chicago, US – has received a USD 1.5 million grant from the US Department of Defense. The grant will finance a clinical trial to examine the benefits (function, biomechanics, metabolics and user satisfaction) of Integrum’s OPRA[TM] Implant System compared to a traditional socket prosthesis system in three individuals with lower-limb amputations.Shirley Ryan AbilityLab is a global

Notice of extraordinary general meeting in NeoDynamics AB (publ)

The shareholders in NeoDynamics AB (publ), corp. reg. no 559014-9117 (the “Company”) are hereby convened to an extraordinary general meeting on Monday 3 April 2023, at 15.30 at the Company’s premises on Lejonvägen 14, Lidingö, Sweden.Right to participate Shareholders who wish to participate in the general meeting must: · be registered in his/her/its own name (not nominee-registered) in the share register kept by Euroclear Sweden AB on Friday 24 March 2023 (the record date), and · notify his/her/its intention to attend the general meeting to the Company no later than Thursday 30

Immunovia appoints Karl Stone as new chief operating officer to develop R&D and operations

LUND, SWEDEN – Immunovia (Nasdaq Stockholm: IMMNOV), the diagnostics company that has launched the world’s first blood-based test dedicated to the early detection of pancreatic cancer, today announced the appointment of Karl Stone as Chief Operating Officer effective 1 March, 2023.    As anticipated when the new management structure was announced in October 2022, Immunovia has now added a new Chief Operating Officer role to its executive team to align with strategic priorities and focus on the US commercialization of the IMMray™ PanCan-d test. The Chief Operating Officer will be

Cereno Scientific announces issuance of European patent for drug candidate CS585

Cereno Scientific (XSAT: CRNO B) today announced that drug candidate CS585’s second patent family has obtained a formally issued patent in Europe, one of the largest markets in cardiovascular disease. This strengthens and broadens the intellectual property rights (IPR) for CS585 which currently is in a preclinical development program in collaboration with the University of Michigan.“I am pleased to report that the first patent in Europe for our preclinical drug candidate CS585 has now been formally issued by the European Patent Office as a final step of the approval process. This is a great

NeoDynamics is investigating options to raise long-term capital to enable commercialization of NeoNavia® in the US

On 16 February 2023, NeoDynamics AB (publ) (“NeoDynamics” or the “Company”) announced that the Company’s largest shareholder, Gryningskust Holding AB had provided a loan of SEK 14m to kick-start the planned launch of NeoNavia® in the US. The loan is intended to be converted into shares if the Company issues new shares in the future. The loan matures on 15 August 2023.The board of directors and management of NeoDynamics are currently exploring various options to raise long-term capital to enable commercialization and execution of the Company’s US strategy, following the FDA clearance

HC Andersen Capital Events 01/03: Meet the top management in Audientes, Green Hydrogen Systems & Hafnia

HC Andersen Capital is hosting excting digital events where you can meet and ask questions directly to the top management. It is free for all to attend.Audientes - Presentation of 2022 Year-End reportAudientes released their 2022 Year-end report on 28 February 2023. Audientes’ CEO Steen Thygesen will present the results in a virtual live event followed by a Q&A session on 1 March 2023. Here you can get an update on the results and the recent business development, and ask your questions live.   Disclaimer:HC Andersen Capital receives payment from Audientes for a Corporate Visibility/

Episealer® health economy publication accepted for publication in Journal of ISAKOS

Episurf Medical (Nasdaq: EPIS B) today announces that results from a cost utility study, focusing on the health economic aspects of the treatment with the Episealer® knee implant, has been accepted for publication in the Journal of ISAKOS. The manuscript, with the title “Individualized metal implants for focal cartilage lesions in the knee can be cost effective: A simulation on 47-year-olds in a Swedish setting” by L. Bernfort et al. assesses the cost utility of a resurfacing knee implant for focal cartilage lesions compared with the biological treatment option microfracture, being the

Invitation to Nobia’s Capital Markets Update on March 22

Nobia has the pleasure of inviting institutional investors, financial analysts and media to its Capital Markets Update on 22 March 2023 in Jönköping, Sweden. The event will be hosted by Nobia’s CEO Jon Sintorn, together with colleagues from the Group Management team.The day will provide an update on the Group’s strategy and execution, and includes an on-site tour of Nobia’s new Nordic factory that is under construction in Jönköping. The event will be held as a physical meeting starting at 10:30 at the Quality Hotel Match, located next to the train station in Jönköping (there are trains

Interim report May – Jan 2022/23: Solid growth and stronger market presence

The period Nov 1st 2022 – Jan 31st 2023 ▪    Net sales amounted TSEK 18 680 (12 636), which is an increase of 48% compared with the corresponding period last year. The growth in the US market is 40% compared with the corresponding period last year. ▪    Operating loss amounted to TSEK -13 773 (503) ▪    Net profit amounted to TSEK -14 176 (541) ▪    Cashflow from operating activities amounted to TSEK -14 083 (863) ▪    Earnings per share amounted to -0,74 SEK (0,03) Significant events in the quarter ▪    Continue to add well renowned hospitals, where NYU Langone, ranked

Change of management at Veidekke Bygg Bergen

Thor Småbrekke will be taking over from Erlend Bygness as the Regional Manager of Veidekke Bygg Bergen on 1 March. Småbrekke has played a key role in the development of Constructa Entreprenør and he is now taking over responsibility in Bergen following Veidekke's acquisition of Constructa was formalised in November 2022. Erlend Bygnes will continue to work for Veidekke in a new capacity."I’m very pleased that both Thor and Erlend are taking on exciting new roles at Veidekke Bygg Bergen. Erlend has made it clear that, after 30 years in various management positions at Veidekke in Bergen, he

Zimpler appoints Chief Product Officer to drive product innovation further

Stockholm, 1 March 2023 — Zimpler, a Swedish fintech company providing seamless and secure account-to-account payments, announced today the appointment of Stefan Andersson as its Chief Product Officer. He will take on the role starting 20 March 2023. In the newly created role, Andersson will lead Zimpler’s product roadmap and will focus on driving the expansion agenda, which includes expanding geographical coverage in Europe and establishing the product in Latin America. He will also further innovation within the company’s product and features to cater for the growing demand for more

There are no items matching the current filter
There are no more items matching the current filter
Back to top